Plenty of good news for ADx NeuroSciences. Today, the Ghent-based Alzheimer specialist has announced the end of its third capital round as well as a new agreement with their American partner Quanterix. Both the capital raise and the new deal are milestones for ADx and will fuel the company’s growth in the coming years.